AnaSpec Introduces 69 New Antibodies

San Jose, CA – April 2007 — Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added sixty-nine (69) new antibodies to its growing collection of catalog antibodies. The targeted research areas for these antibodies include cancer research and a host of other applications.

Anti-AFP - Cat# 53213, 50 µg

Anti-ALK/p80 - Cat# 53215, 50 µg

Anti-alpha Fetoprotein (AFP) - Cat# 53217, 50 µg

Anti-Bcl-6 - Cat# 53258, 50 µg

Anti-Bcl-6 - Cat# 53259, 50 µg

Anti-Cathepsin D - Cat# 53304, 50 µg

Anti-C-erbB-2 (pY1248) - Cat# 29607, 50 µg

Anti-NY-ESO-1 - Cat# 53726, 50 µg

Anti-p130/ Rb2 - Cat# 53731, 50 µg

Anti-p130cas - Cat# 53732, 50 µg

Anti-p15INK4b - Cat# 53734, 50 µg

Anti-Patched - Cat# 53762, 50 µg

Anti-Plasma Cell Marker - Cat# 53781, 50 µg

Anti-PPAR-gamma - Cat# 53790, 50 µg

Anti-Prostate Specific Acid Phosphatase - Cat# 53801, 50 µg

Anti-Prostate Specific Antigen - Cat# 53802, 50 µg

Anti-pS2 - Cat# 53804, 50 µg

Anti-PSA - Cat# 53805, 50 µg

Anti-PSCA - Cat# 53806, 50 µg

Anti-Rab1A - Cat# 53811, 50 µg

Anti-Rad51 - Cat# 53812, 50 µg

Anti-Raf -A - Cat# 53813, 50 µg

Anti-Ran - Cat# 53817, 50 µg

Anti-Ras - Cat# 53818, 50 µg

Anti-RCC1 - Cat# 53820, 50 µg

Anti-Renal Cell Carcinoma - Cat# 53822, 50 µg

Anti-Survivin - Cat# 53873, 50 µg

Anti-TAB1 - Cat# 53881, 50 µg

Anti-TAG-72 - Cat# 53883, 50 µg

Anti-TDT - Cat# 53888, 50 µg

Anti-Tenascin - Cat# 53890, 50 µg

Anti-Thyroglobulin - Cat# 53905, 50 µg

Anti-TrxR2 - Cat# 53926, 50 µg

Anti-Wilm's Tumor Protein - Cat# 53949, 50 µg

Anti-Wilm's Tumor Protein - Cat# 53950, 50 µg

Anti-ZAP-70 - Cat# 53958, 50 µg

Anti-beta-Catenin pS675 - Cat# 29619, 50 µg

Anti-GFP Tag - Cat# 29779, 50 µg

Anti-GFP Tag (CT) - Cat# 53882, 50 µg

Anti-GFP Tag (IN) - Cat# 53611, 50 µg

Anti-GFP Tag (NT) - Cat# 54045, 50 µg

Anti-His-tag - Cat# 29673, 50 µg

L-Plastin - Cat# 53621, 50 µg

Luciferase - Cat# 53622, 50 µg

Maltose Binding Protein - Cat# 53624, 50 µg

MAP1B - Cat# 53626, 50 µg
Microtubule-associated protein 1B

MCM2 - Cat# 53629, 50 µg
Mini-Chromosome Maintenance 2

MCM5 - Cat# 53630, 50 µg
Mini-Chromosome Maintenance5

Melanoma (gp100) - Cat# 53639, 50 µg

Mesothelin - Cat# 53640, 50 µg

mGluR1 - Cat# 53641, 50 µg

mGluR5 - Cat# 53642, 50 µg

MHC II (HLA-DP and DR) - Cat# 53649, 50 µg

MHC II (HLA-DR) Ia - Cat# 53653, 50 µg

MIP-1alpha - Cat# 53663, 50 µg
Macrophage inflammatory protein-1 alpha

MITF - Cat# 53664, 50 µg
Microphthalmia Transcription Factor

Anti-alpha Internexin - Cat# 53218, 50 µg

Anti-CD23 - Cat# 29682, 50 µg

Anti-MOG 35-55 - Cat# 54003, 50 µg

Anti-Myelin Basic Protein - Cat# 53691, 50 µg

Anti-Neurofilament (200 kDa & 68 kDa) - Cat# 53706, 50 µg

Anti-Neurofilament (200 kDa) - Cat# 53705, 50 µg

Anti-Parkin - Cat# 53760, 50 µg

Anti-PMP22 - Cat# 53786, 50 µg

Anti-Synuclein - Cat# 53877, 50 µg

Anti-Synuclein ? - Cat# 53878, 50 µg

Anti-Synuclein ? - Cat# 53879, 50 µg

Anti-Synuclein pan - Cat# 53880, 50 µg

Anti-Toxoplasma Gondii - Cat# 53920, 50 µg

For more information visit www.anaspec.com

Company Info
AnaSpec, Inc. is a leading provider of integrated proteomics solutions to pharmaceutical, biotech, and academic research institutions throughout the world. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents, and combinatorial chemistry. Established in 1993, AnaSpec's headquarters and manufacturing facilities are located in San Jose, CA.